Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan · Delayed Price · Currency is TWD 28.20
+0.15 (0.53%)
Feb 11, 2026, 1:16 PM CST
Perfect Medical Industry Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 72.48 | 89.12 | 40.09 | 14.27 | 38.77 | 100.69 |
Depreciation & Amortization | 58.9 | 56.27 | 56.86 | 55.78 | 48.4 | 39.48 |
Loss (Gain) From Sale of Assets | -0.09 | -0.4 | -1.19 | -1.18 | -0.19 | -0.44 |
Asset Writedown & Restructuring Costs | - | 4.28 | 14.61 | - | - | - |
Stock-Based Compensation | 3.59 | 4.52 | 3.17 | 0.03 | - | 3.02 |
Provision & Write-off of Bad Debts | -0.02 | 0.09 | 0.01 | 0.02 | 0.26 | 0.77 |
Other Operating Activities | -10.14 | -9.75 | 11.71 | 3.82 | 3.98 | 23.11 |
Change in Accounts Receivable | 0.82 | 4.17 | -2.38 | -2.37 | -3.7 | -5.31 |
Change in Inventory | 12.96 | -25.15 | 14.21 | 47.83 | -73.02 | -57.81 |
Change in Accounts Payable | -1.02 | 9.08 | 3.15 | -9.62 | -13.3 | 7.63 |
Change in Unearned Revenue | 4.47 | -1.09 | -1.46 | 1.05 | 1.56 | 0.43 |
Change in Other Net Operating Assets | -18.5 | 12.4 | 11.09 | -4.02 | 1.68 | 6.61 |
Operating Cash Flow | 123.44 | 143.54 | 149.87 | 105.61 | 4.44 | 118.19 |
Operating Cash Flow Growth | -4.40% | -4.22% | 41.91% | 2277.07% | -96.24% | 23.16% |
Capital Expenditures | -101.05 | -97.7 | -64.7 | -52.75 | -103.34 | -117.71 |
Sale of Property, Plant & Equipment | 1.71 | 6.98 | 13.1 | 5.88 | 2.42 | 4.76 |
Sale (Purchase) of Intangibles | -1.74 | -1.54 | -1.61 | - | -0.24 | -0.13 |
Investment in Securities | 0.34 | -13.27 | -19.01 | - | 48.09 | -40.32 |
Other Investing Activities | -48.82 | -5.4 | 8.64 | 2.48 | -8.77 | -36.19 |
Investing Cash Flow | -149.57 | -110.92 | -63.57 | -44.39 | -61.84 | -189.59 |
Short-Term Debt Issued | - | 130 | 280 | 545.13 | 563.62 | 428.25 |
Long-Term Debt Issued | - | 1,231 | 1,447 | 93 | - | 90 |
Total Debt Issued | 983.99 | 1,361 | 1,727 | 638.13 | 563.62 | 518.25 |
Short-Term Debt Repaid | - | -210 | -234.67 | -717.68 | -423.25 | -373.73 |
Long-Term Debt Repaid | - | -1,180 | -1,491 | -37.16 | -27.71 | -15.67 |
Total Debt Repaid | -821.21 | -1,390 | -1,726 | -754.83 | -450.96 | -389.4 |
Net Debt Issued (Repaid) | 162.78 | -29.26 | 0.49 | -116.71 | 112.66 | 128.85 |
Issuance of Common Stock | 48.2 | 107.87 | - | 45.6 | 27.89 | - |
Common Dividends Paid | -110.96 | -65.14 | -16.9 | -14.43 | -58.77 | -27.43 |
Other Financing Activities | 0.37 | - | - | - | - | - |
Financing Cash Flow | 100.39 | 13.47 | -16.4 | -85.54 | 81.77 | 101.42 |
Foreign Exchange Rate Adjustments | -19.87 | -0.33 | -1.24 | -2.19 | -0.01 | -3.43 |
Net Cash Flow | 54.4 | 45.77 | 68.67 | -26.5 | 24.37 | 26.6 |
Free Cash Flow | 22.39 | 45.84 | 85.17 | 52.87 | -98.89 | 0.49 |
Free Cash Flow Growth | -65.69% | -46.18% | 61.11% | - | - | -98.96% |
Free Cash Flow Margin | 3.04% | 6.16% | 11.60% | 7.81% | -13.65% | 0.06% |
Free Cash Flow Per Share | 0.41 | 0.90 | 1.85 | 1.20 | -2.43 | 0.01 |
Cash Interest Paid | 4.44 | 3.53 | 4.32 | 4.35 | 2.76 | 1.93 |
Cash Income Tax Paid | 19.05 | 20 | 12.13 | 20.38 | 23.76 | 9 |
Levered Free Cash Flow | -17.27 | 2.4 | 71.03 | 33.96 | -104.18 | -10.28 |
Unlevered Free Cash Flow | -14.34 | 4.73 | 73.76 | 36.74 | -102.33 | -9 |
Change in Working Capital | -1.28 | -0.59 | 24.61 | 32.88 | -86.78 | -48.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.